- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
February 10, 2015 – Efficacy of topical application of human breast milk on atopic eczema healing among infants.
January 9, 2014 – A basic skin care regimen should focus on the fundamental aspects of atopic dermatitis. In atopic dermatitis there’s a skin barrier function problem.
January 9, 2015 – NEA asked this question on Facebook recently: In order for prescription medications to be most effective, a proper bathing and moisturizing regimen is required. What’s your bathing and moisturizing routine?
Here’s what people had to say:
January 6, 2015 – For the first time, a team led by researchers at the Icahn School of Medicine at Mount Sinai has proven that atopic dermatitis, also known as eczema, is an immune-driven (autoimmune) disease.
December 15, 2014 – Patients on subcutaneous dupilumab at 300 mg once weekly showed nearly an 80% reduction from baseline in Eczema Area and Severity Index scores after 16 weeks of treatment.
November 20, 2014 – Contact Dermatitis (CD) is a term used to describe the itchy skin reaction that can occur following topical contact (and sometimes oral, or airborne) with allergy-producing chemicals in the environment.
November 5, 2014 – NEA asked this question on Facebook recently: What are your tips for seborrheic dermatitis? Here’s what people had to say:
November 5, 2014 – Seborrheic dermatitis is a common skin condition that affects the areas of the body that have a high density of oil-producing (sebaceous) glands. It affects 1 to 5 percent of the general population, and often has a chronic, relapsing course.
April 10, 2014 – The investigational drug REGN668, a monoclonal antibody that modulates interleukins 4 and 13, significantly improved overall quality of life and pruritus in patients with severe, longstanding atopic dermatitis.
March 11, 2014 – Biologics are a relatively new class of medications that target specific parts of the immune system and have revolutionized the treatment of many chronic illnesses. A number of such agents are currently approved by the United States Food and Drug Administration (FDA) for one or more indications,